Financhill
Back

Apellis Pharmaceuticals Vs. Nukkleus Industry Stock Comparison

Sell
37

APLS
Apellis Pharmaceuticals

Last Price:
$19.36
Seasonality Move:
-18.71%
Sell
18

NUKK
Nukkleus

Last Price:
$7.98
Seasonality Move:
15977.66%
Sell
37
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $19.35. The Score for APLS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
Nukkleus (NUKK) is a Sell

Is Nukkleus a Buy, Sell or Hold?

  • The current Nukkleus [NUKK] share price is $7.76. The Score for NUKK is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • NUKK is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $19.35
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.

NUKK Stock Price Chart

What is Nukkleus's stock price today?

  • The Nukkleus share price today is $7.76
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUKK is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.27 Buy
Relative Strength Index (14 RSI): 56.68 Buy
Chaikin Money Flow: -833286 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.69 - 19.29) Buy
Bollinger Bands (100): (17.11 - 23.71) Sell

NUKK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.08 Buy
Relative Strength Index (14 RSI): 30.41 Sell
Chaikin Money Flow: -151462 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.44 - 12.54) Sell
Bollinger Bands (100): (11.28 - 16.32) Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.88 Buy
20-day SMA: 18.3 Buy
50-day SMA: 18.24 Buy
200-day SMA: 25.25 Sell
8-day EMA: 19.04 Buy
20-day EMA: 18.61 Buy
50-day EMA: 18.89 Buy
200-day EMA: 25.71 Sell

NUKK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.54 Sell
20-day SMA: 10.53 Sell
50-day SMA: 13.5 Sell
200-day SMA: 13.03 Sell
8-day EMA: 6.05 Buy
20-day EMA: 3.4 Buy
50-day EMA: 1.58 Buy
200-day EMA: 0.43 Buy

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.18 per share, an increase this year of $0.28 per share, and an increase next year of $0.56 per share.

Nukkleus Earnings Growth & NUKK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nukkleus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):